SSSandeep Samant

Sandeep Samant

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sandeep Samant has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Postoperative Opioid Receipt After Parotidectomy and Associations With Persistent Opioid Use Disorder

    by Asher C. Park, Milan P. Fehrenbach, Larry W. Wang, Oluwatobiloba Ayo‐Ajibola, Urjeet A. Patel, Sandeep Samant, Katelyn O. Stepan

    Objective: To investigate the association between postoperative opioid receipt and the development of persistent opioid use disorder following parotidectomy. Study Design: Propensity‐matched retrospective cohort study. Setting: United States. Methods: The TriNetX Research Network was queried for adult patients who underwent parotidectomy from 2010 to 2023. Patients with a history of opioid abuse/dependence or underwent surgery with anesthesia within 9 months postoperatively were excluded. The opioid cohort included patients that received hydrocodone, oxycodone, or codeine postoperatively, whereas the nonopioid cohort included patients that did not receive these opioids postoperatively. Cohorts were propensity score matched for patient demographics, psychiatric and preoperative pain diagnoses, as well as for possible procedures performed concurrently alongside parotidectomy. The primary outcome was risk of persistent opioid use, defined as new opioid use 3 to 9 months following surgery. Secondary outcomes included the number of emergency department and office/outpatient visits within 1 and 3 months postoperatively and the risk of opioid abuse/dependence. Results: After propensity matching, each cohort had 3858 patients. The opioid cohort had an increased risk of developing new persistent opioid use (RR = 1.321, P < .001) compared to the nonopioid cohort. Opioid receipt was also associated with increased office/outpatient visits within 1 ( P < .001) and 3 months ( P < .001). The number of emergency department visits and risk of opioid abuse/dependence were not significantly different between cohorts. Conclusion: Opioid prescription following parotidectomy was associated with an increased risk of persistent opioid use disorder and the number of postoperative office visits, emphasizing the need for further investigation of opioid‐sparing analgesia protocols following parotidectomy.


  • Open Access

    Non‐Tobacco Nicotine Use and Complications in Free Flap Repair in Head and Neck Cancer

    by Asher C. Park, Larry Wang, Milan P. Fehrenbach, Oluwatobiloba Ayo‐Ajibola, Urjeet A. Patel, Sandeep Samant, Katelyn O. Stepan

    Objective: Assess associations between non‐tobacco nicotine usage and free flap repair complications in head and neck cancer (HNC) patients.Study Design: Propensity‐matched retrospective cohort study.Methods: The TriNetX database was queried for HNC patients who underwent free flap procedures from 2010 to 2024. Among these patients, the NIC cohort was defined as those with dependence on nicotine prior to surgery, but without the use of cigarettes, chewing tobacco, or other tobacco products. The non‐NIC cohort was defined as patients with no nicotine dependence, cigarettes, chewing tobacco, or other tobacco product use prior to surgery. Cohorts were propensity‐matched based on demographics and comorbidities. Primary outcomes included free flap failure, blood vessel repair, and other revisionary procedures (associated with wound disruption or repair) within 30 days of the primary reconstruction. Secondary outcomes included infection, pneumonia, cardiopulmonary complications, and hematoma within 30 days.Results: Following propensity matching, 1324 patients were included in each cohort. Across all free flaps, non‐tobacco nicotine use was associated with a significantly increased risk of other revision procedures (RR: 1.230 [95% CI: 1.013, 1.493], p = 0.036), sepsis (RR: 1.563 [95% CI: 1.009, 2.419], p = 0.045), fistula (RR: 1.588 [95% CI: 1.041, 2.423], p = 0.032), cardiovascular complications (RR: 1.420 [95% CI: 1.054, 1.914], p = 0.021), pneumonia (RR: 2.055 [95% CI: 1.570, 2.689], p < 0.001), and pulmonary embolism (RR: 2.220 [95% CI: 1.217, 3.933], p = 0.008).Conclusions: Non‐tobacco nicotine use is associated with an increased risk of postoperative complications in HNC patients following free flap reconstruction. Screening for non‐tobacco nicotine use in surgical candidates may better inform clinical management and counseling.Level of Evidence: III


  • Open Access

    Social Vulnerability Index as a Tool to Evaluate the Distribution of Head and Neck Oncology Surgeons

    by Asher C. Park, Milan P. Fehrenbach, Ryan J. Davis, Oluwatobiloba Ayo‐Ajibola, James C. Wang, Urjeet A. Patel, Sandeep Samant, Katelyn O. Stepan

    Objective: To assess the geographic distribution of head and neck oncology surgeons (HNS) in the U.S. and to evaluate the association of this distribution with neighborhood‐level social determinants of health as measured by the Social Vulnerability Index (SVI).Methods: U.S.‐based HNSs and their practice addresses were obtained from publicly available sources. The geographic distribution of HNSs was analyzed at the state, county, and metropolitan statistical area levels. U.S. census tracts were scored on a continuous scale of increasing social vulnerability (0–1) across Overall SVI and four subthemes: Socioeconomic Status, Household Composition‐Disability Status, Racial‐Ethnic Minority Status, and Housing‐Transportation Status. The distance from each census tract to the nearest HNS was calculated, and univariable linear regression analyses assessed associations between SVI scores and distances.Results: This study included 609 HNSs that were disproportionately distributed at the state, county, and MSA levels. Higher vulnerability scores in Overall SVI (β = 12.9 [95% CI: 11.05, 14.69]), Socioeconomic Status (β = 11.5 [95% CI: 9.67, 13.32]), Household Composition‐Disability Status (β = 10.4 [95% CI: 8.61, 12.27]), and Housing‐Transportation Status (β = 18.2 [95% CI: 16.42, 20.06]) were associated with significantly increased distance to the nearest HNS, while higher vulnerability scores among Racial‐Ethnic Minority Status were associated with significantly decreased distance to the nearest HNS (β = −25.8 [95% CI: −27.64, −24.01]).Conclusion: Inequities in the distribution of HNSs highlight the need for targeted strategies to improve access to head and neck cancer care. SVI may help identify especially vulnerable areas lacking access to this care.


  • Open Access

    Association of Neighborhood‐Level Area Deprivation with Demographics and Outcomes in Oropharyngeal Squamous Cell Carcinoma

    by Shravan Asthana, Asher C. Park, Abhinav Talwar, Kirsten B. Burdett, Christopher Puchi, Ahmed Ibrahim, Olivia Dunne, Urjeet Patel, Sandeep Samant, Katelyn O. Stepan

    Objective: To characterize neighborhood‐level area deprivation's association with oropharyngeal carcinoma clinicodemographics, tumor staging, recurrence, and overall survival.Study Design: Retrospective study.Setting: Single institution academic medical center.Methods: Patients diagnosed with oropharyngeal squamous cell carcinoma (OPSCC) between 2007 and 2022 at our institution were included in this study. The Area Deprivation Index (ADI) was used to quantify neighborhood‐level disadvantage based on patients’ primary residence at the time of their diagnosis. Continuous variables were compared between groups using the Wilcoxon rank sum test. For categorical variables, proportions were compared using Fisher's exact test. Overall survival (OS) and recurrence‐free survival (RFS) distributions were estimated using the Kaplan‐Meier method and log‐rank test. OS and RFS were further assessed by univariable and multivariable analyses performed using the Cox proportional hazards model.Results: The higher ADI (more disadvantaged) group consisted of a significantly greater proportion of Black race (P < .001), 10+ pack‐year smoking history (P = .003), and Medicare patients (P = .018). On logistic regression analysis, neither ADI nor other social factors were significantly associated with increased likelihood of advanced clinical staging in the p16 positive OPSCC population. Furthermore, while ADI did not correspond with significant differences in survival, multivariate cox regression model demonstrated that “Other” insurance type (Medicaid and uninsured) (hazard ratio [HR] = 10.1, P = .008), age at diagnosis (1.10, P < .001), and advanced clinical staging (HR = 3.25, P = .004) were all significantly associated with increased HR of death.Conclusion: While ADI may not be significantly associated with outcomes in HPV‐related OPSCC patients, this study revealed significant sociodemographic and risk factor differences across ADIs, as well as individual factors influencing prognosis. These findings emphasize the need for a comprehensive approach to understanding factors influencing HPV‐related OPSCC incidence and prognosis.


  • Evaluating dysphagia and xerostomia outcomes following transoral robotic surgery for patients with oropharyngeal cancer

    by Mitesh P. Mehta, Rebecca Prince, Zeeshan Butt, Bryce E. Maxwell, Brittni N. Carnes, Urjeet A. Patel, Katelyn O. Stepan, Bharat B. Mittal, Sandeep Samant

    Background: We assessed long‐term patient‐reported dysphagia and xerostomia outcomes following definitive surgical management with transoral robotic surgery (TORS) in patients with oropharyngeal cancer (OPC) via a cross‐sectional survey study.Methods: Patients with OPC managed with primary oropharyngeal surgery as definitive treatment at least 1 year ago between 2015 and 2019 were identified. The M. D. Anderson Dysphagia Inventory (MDADI) and Xerostomia Inventory (XI) scores were compared across treatment types (i.e., no adjuvant therapy [TORS‐A] vs. adjuvant radiotherapy [TORS+RT] vs. adjuvant chemoradiotherapy [TORS+CT/RT]).Results: The sample had 62 patients (10 TORS‐A, 30 TORS+RT, 22 TORS+CT/RT). TORS‐A had clinically and statistically significantly better MDADI scores than TORS+RT (p = 0.03) and TORS+CT/RT (p = 0.02), but TORS+RT and TORS+CT/RT were not significantly different. TORS‐A had clinically and statistically significantly less XI than TORS+RT (p < 0.01) and TORS+CT/RT (p < 0.01).Conclusions: Patients with OPC who have undergone TORS+RT or TORS+CT/RT following surgery face clinically worse dysphagia and xerostomia outcomes relative to patients who undergo TORS‐A.